World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

PRIMARY URETHRAL SQUAMOUS CELL CARCINOMA OF THE BULBAR URETHRA IN ELDERLY PATIENT: A CASE REPORT AND REVIEW OF THE LITERATURE

*Dr. Abdelmalik Mouzount, Karam Yatribi, Omar Elallam, Wilfried Mossé, Sanaa El Majjaoui, Hanan ElKacemi, Tayeb Kebdani, Noureddine Benjaafar

ABSTRACT

Primary urethral carcinoma (PUC) is a rare diseases which account for only 1% of all male malignancies. The rarity of the disease has prevented prospective studies and most of the treatment data come from case studies and small case series. Bulbar urethral disease carries a worse prognosis because the diagnosis is often delayed due to the nonspecific symptoms. We report an 82-year-old with urethral squamous cell carcinoma. The man presented with a 5 month history of recurrent urinary tract infection, dysuria and hematuria. The patient refused an aggressive surgery, and was desirous of organ preservation, therefore surgical tumor debulking by transurethral resection was performed, followed by chemoradiation therapy using volumetric modulated arc therapy. The patient showed residual tumor on pelvic MRI performed 2 month after and a salvage surgery was needed. In this paper we discuss the management of PUC with a review of the literature.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR